Assessment of blood clotting factors, including pro-clotting factors such as fibrinogen, prothrombin, and factors XI, XII, and XIII, and natural anticoagulants such as antithrombin is critical in understanding the pathophysiological processes underlying the development of COVID-19 and its complications. The gene discussed is F2; the disease is COVID-19.